Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cyclacel Pharmaceuticals | CYCC | Sep 19, 2024 | 1.02 | -2.39 |
Cyclacel Pharmaceuticals Pref | CYCCP | Sep 19, 2024 | 7.00 | 0.00 |
Cyclerion Therapeutics | CYCN | Sep 19, 2024 | 2.83 | +0.71 |
Cyclo Therapeutics | CYTH | Sep 19, 2024 | 0.68 | +5.18 |
Cyngn | CYN | Sep 19, 2024 | 3.75 | -1.57 |
Cytek Biosciences | CTKB | Sep 19, 2024 | 5.29 | +4.55 |
Cytokinetics | CYTK | Sep 19, 2024 | 55.60 | -0.61 |
Cytomed Therapeutics | GDTC | Sep 19, 2024 | 1.55 | -1.27 |
CytomX Therapeutics | CTMX | Sep 19, 2024 | 1.17 | -1.68 |
Cytosorbents | CTSO | Sep 19, 2024 | 1.42 | 0.00 |
D-MARKET Electronic Services & Trading ADR | HEPS | Sep 19, 2024 | 2.35 | +0.86 |
D-Wave Quantum | QBTS | Sep 19, 2024 | 0.96 | -0.58 |
D.R. Horton | DHI | Sep 19, 2024 | 197.06 | +1.48 |
Dada Nexus ADR | DADA | Sep 19, 2024 | 1.31 | +6.50 |
Daily Journal | DJCO | Sep 19, 2024 | 512.49 | +3.08 |
Dakota Gold | DC | Sep 19, 2024 | 2.32 | +0.43 |
Daktronics | DAKT | Sep 19, 2024 | 12.44 | +2.05 |
DallasNews A | DALN | Sep 19, 2024 | 4.40 | +3.04 |
Dana | DAN | Sep 19, 2024 | 10.47 | +3.05 |
Danaher | DHR | Sep 19, 2024 | 276.43 | +1.67 |
Danaos | DAC | Sep 19, 2024 | 81.73 | +2.01 |
Danimer Scientific | DNMR | Sep 19, 2024 | 0.38 | +12.09 |
DAQO New Energy ADR | DQ | Sep 19, 2024 | 17.39 | +2.60 |
Darden Restaurants | DRI | Sep 19, 2024 | 172.27 | +8.25 |
Daré Bioscience | DARE | Sep 19, 2024 | 3.36 | +4.02 |
DarioHealth | DRIO | Sep 19, 2024 | 1.00 | +11.11 |
Darling Ingredients | DAR | Sep 19, 2024 | 37.10 | +3.26 |
Data I/O | DAIO | Sep 19, 2024 | 2.48 | +3.33 |
Data Storage | DTST | Sep 19, 2024 | 3.84 | +1.59 |
Datadog A | DDOG | Sep 19, 2024 | 115.52 | +2.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.